Growth rate reaccelerates to 16% for the Coveo core platform(2) Generative AI solutions drove ~50% of new business during the quarter Broadens relationship with SAP Coveo reports in U.S. dollars and in accordance with International Financial Reporting Standards (“IFRS”) Coveo (TSX: CVO), the leader in AI-Relevance, delivering best-in-class search and generative experiences that maximize business […]

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring,today reported its financial and operational results for the second quarter ended June 30, 2025. https://mma.prnewswire.com/media/373722/Zynex_Medical_Logo.jpg Management Commentary “In the second quarter of 2025, we completed two transformational events. First,

Amgen (NASDAQ:AMGN) today announced that it will report its second quarter 2025 financial results onTuesday, August 5, 2025, after the close of theU.S.financial markets. The announcement will be followed by a conference call with the investment community at4:30 p.m. ET. Participating in the call fromAmgenwill beRobert A. Bradway, chairman and chief executive officer, and other

Solesence Reports Second Quarter 2025 Financial Results Strong commercial execution drove revenue growth of 56% to $20.4 million GlobeNewswire July 31, 2025 ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) — Solesence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the second quarter

NEWARK, CALIFORNIA / ACCESS Newswire / July 31, 2025 / Altigen Technologies (OTCQB:ATGN), a leading Silicon Valley-based Microsoft Cloud Communications Solutions provider, announced today its financial results for the third quarter ended June 30, 2025. Key Financial Highlights (3Q 2025 versus 3Q 2024) Net Revenue increased 7% to $3.52 million Cloud services revenue decreased 1%

BOSTON, MA / ACCESS Newswire / July 31, 2025 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. ("Radius" or the "Company"), a specialty biopharmaceutical company focused on bone health and related areas, announced today that the U.S. District Court for the District of Massachusetts has ruled in favor of Radius and

(NASDAQ:CACC), Southfield, Michigan, July 31, 2025 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) today announced consolidated net income of $87.4 million, or $7.42 per diluted share, for the three months ended June 30, 2025. Adjusted net income, a non-GAAP financial measure, for the

(NASDAQ:RYET), NANCHANG, China, July 31, 2025 (GLOBE NEWSWIRE) — Ruanyun Edai Technology Inc. (“Ruanyun” or the “Company”) (NASDAQ: RYET), a leading AI-powered education technology company in China, today announced its financial results for the fiscal year ended March 31, 2025. Key Financial Performance Highlights Revenue decreased by 27.0% to $6.7 million in FY2025, primarily due

(NasdaqGM:CRVS), SOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on August 7, 2025 at 4:30 pm ET (1:30 pm PT) to provide a business update and report second quarter 2025 financial results. The

(NasdaqGM:SAMG), NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) (the “Company” or “Silvercrest”) today reported the results of its operations for the quarter ended June 30, 2025. Business Update Discretionary assets under management (“AUM”) increased $1.0 billion during the second quarter, primarily due to strong markets. While net